Your browser doesn't support javascript.
loading
Chemoradiotherapy with FOLFOX plus cetuximab in locally advanced oesophageal cancer: The GERCOR phase II trial ERaFOX.
Lledo, Gérard; Huguet, Florence; Chibaudel, Benoist; Di Fiore, Frédéric; Mineur, Laurent; Galais, Marie-Pierre; Artru, Pascal; Blondin, Valérie; Dupuis, Olivier; Abdiche, Menouar Samir; Jovenin, Nicolas; Pozet, Astrid; Bonnetain, Franck; Attia, Mohamed; Dahan, Laetitia; de Gramont, Aimery.
Affiliation
  • Lledo G; Gastroenterology Department, Private Hospital Jean Mermoz, Lyon, France; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France. Electronic address: lledogerard@aol.com.
  • Huguet F; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France; Radiation Oncology Department, Tenon Universitary Hospital, Assistance Publique - Hôpitaux Universitaires Paris Est, University Pierre and Marie Curie Paris 6, Institut Universitaire de Cancérologie, Paris, France.
  • Chibaudel B; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France; Medical Oncology Department, Saint-Antoine Universitary Hospital, Paris, France.
  • Di Fiore F; Digestive Oncology Unit, Hepatogastroenterology Department, University Hospital, Rouen, France.
  • Mineur L; Radiation Oncology Department, Institut Sainte-Catherine, Avignon, France.
  • Galais MP; Digestive Oncology Unit, Centre Régional François Baclesse, Caen, France.
  • Artru P; Gastroenterology Department, Private Hospital Jean Mermoz, Lyon, France.
  • Blondin V; Digestive Oncology Unit, Hepatogastroenterology Department, University Hospital, Rouen, France.
  • Dupuis O; Clinique Victor Hugo, Le Mans, France.
  • Abdiche MS; Radiation Oncology Department, Robert Boulin Hospital, Libourne, France.
  • Jovenin N; Medical Oncology Department, Institut Jean Godinot, Reims, France.
  • Pozet A; Methodology and Quality of Life Unit in Cancer, EA 3181, Universitary Hospital of Besançon, Besançon, France.
  • Bonnetain F; Methodology and Quality of Life Unit in Cancer, EA 3181, Universitary Hospital of Besançon, Besançon, France.
  • Attia M; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France.
  • Dahan L; Digestive Oncology Unit, University Hospital la Timone, Marseille, France.
  • de Gramont A; Groupe Coopérateur Multidisciplinaire en Oncologie (GERCOR), Paris, France; Medical Oncology Department, Saint-Antoine Universitary Hospital, Paris, France.
Eur J Cancer ; 56: 115-121, 2016 Mar.
Article in En | MEDLINE | ID: mdl-26845174
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction / Chemoradiotherapy / Cetuximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2016 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Esophageal Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Esophagogastric Junction / Chemoradiotherapy / Cetuximab Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Europa Language: En Journal: Eur J Cancer Year: 2016 Type: Article